1. Home
  2. Geneviève Waeterloos
  3. Geneviève Waeterloos

Primary tabs

Search
Limit to
Export 72 results:
Filters: Author is Geneviève Waeterloos
2022
Auditors experience with remote audits:Preparatory phase, Waeterloos, Geneviève, Tesolin L., and Van Molle Wim , OMCL annual meeting 2022, 14/06/2022, EDQM, strasbourg, (2022)
EU Batch Release Procedure: Annual Report 2021 - Batch Release of IVMPs, Levi, S., Delferrière A., and Waeterloos Geneviève , 10/06/2022, Strasbourg, France, p.14, (2022)
Module 2: développement et production d'un vaccin - chapitre 3: contrôle de qualité , Waeterloos, Geneviève , 2022 03, https://www.ulb.be/fr/programme/fc-742, (2022)
National perspectives on non-animal approaches for quality control and batch release testing of biologicals and the influence of WHO guidelines, Waeterloos, Geneviève, Florens Morgane, and Ribaucour F , https://www.nc3rs.org.uk/events/nc3rs-workshop-implementing-3rs-who-guidelines-understanding-impact-quality-control-and , 2022 03 02, Virtual conference, London, United Kingdom , (2022)
Panel discussion on the adoption of 3Rs and non-animal approaches for quality control and batch release testing of these products, Waeterloos, Geneviève , https://www.nc3rs.org.uk/events/nc3rs-workshop-implementing-3rs-who-guidelines-understanding-impact-quality-control-and , 2022 03 02, Virtual conference, London, United Kingdom , (2022)
2021
EU Batch Release Procedure: Annual Report 2020 - Batch Release of IVMPs, Levi, S., Delferrière A., and Waeterloos Geneviève , 19/04/2021, Strasbourg, France, p.14, (2021)
How to implement trend analysis, Tesolin, L., Waeterloos Geneviève, Stradiot L., Ribaucour F, Auquier J., and Cuignet L. , Training Saudi Food and Drug Authority, (2021)
OCABR of Covid vaccines, a success story, Waeterloos, Geneviève, and Milne Catherine , Annual OMCL meeting _ General session, 08/09/2021, Issue EDQM, (2021)
2020
Establishment of single dilution assays for animal based potency determinations, Waeterloos, Geneviève, Tesolin L., Ribaucour F, and Delbrassinne Laurence , WHO Webinar: Establishment of a single dilution potency assay, (2020)
EU Batch Release Procedure: Annual Report 2019 - Batch Release of IVMPs, Levi, S., Gisbert Algaba I., Grognet P., and Waeterloos Geneviève , 29/04/2020, Strasbourg, France, p.14, (2020)
2019
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mindset of the manufacturer., Van Molle, Wim , EDQM & European Pharmacopoeia: State-of-the-Art Science for Tomorrow’s Medicines, 19-20 May 2019, Issue EDQM, (2019)
EU Batch Release Procedure: Annual Report 2018 - Batch Release of IVMPs, Gisbert Algaba, I., Grognet P., Levi S., and Waeterloos Geneviève , 25/04/2019, Strasbourg, France, p.14, (2019)
2018
Estimating the Reliability of Low-Abundant Signals and Limited Replicate Measurements through MS2 Peak Area in SWATH, Limonier, Franck , PROTEOMICS, Nov-02-2018, (2018)
2017
An application of mass spectrometry for quality control of biologicals: Highly sensitive profiling of plasma residuals in human plasma-derived immunoglobulin., Limonier, Franck, Van Steendam Katleen, Waeterloos Geneviève, Brusselmans Koen, Sneyers Myriam, and Deforce Dieter , J Proteomics, 2017 Jan 30, Volume 152, p.312-320, (2017)
2016
Belgium, a WHO contracted laboratorium, Waeterloos, Geneviève , Global network of national vaccine control lab, WHO Workshop, 29/8/2016, Issue WHO, NA, (2016)
OMCL's role in OOS evaluation and communication with partners (network, MAH and beyond) and tools available, Waeterloos, Geneviève , OMCL Annual Meeting 2016, 27/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)
Tetravac/Pentavac vaccines: follow-up on the aP immunogenicity assay situation, Domicent, C., Lejeune M., Stygelbout V., Brusselmans Koen, and Waeterloos Geneviève , OMCL ANNUAL MEETING 2016, 26/5/2016, Issue European Directorate for the Quality of Medicines & HealthCare (EDQM),Council of Europe, NA, (2016)
2015
Accelerated development of vaccine benefit-risk collaboration in Europe, van der Aa, Lieke Maria, Mahy Patrick, Lernout Tinne, and Waeterloos Geneviève , Annual OMCL meeting, 0/6/2015, Issue EDQM, NA, (2015)
Batch release of vaccines in Europe: from method transfer to first commercial batch available on the market. Straightforward approach that requires a proactive mind-set of the manufacturer., Van Molle, Wim, Tesolin L., Brusselmans Koen, and Waeterloos Geneviève , PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing Countries, 0/11/2015, Issue PDA Europe, Berlin, Germany, (2015)
Het Wetenschappelijk Instituut Volksgezondheid (WIV-ISP) organiseert de 20e bijeenkomst van het Europese netwerk van de Official Medicines Control Laboratories (OMCL), Waeterloos, Geneviève , 06/2015, Brussels, Belgium, (2015)
Impact on the Immmunogenicity and Safety of Tetanus Toxoid Vaccine in Controlled Temperature Chain and Standard Cold chain (WHO/Epicentre project), Waeterloos, Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, (2015)
Le WIV-ISP organise la 20ème assemblée du réseau européen des Laboratoires Officiels de Contrôle des Médicaments (OMCL), Waeterloos, Geneviève , 0/6/2015, Brussel, Belgium, (2015)
The Quality Control of Plasma-Derived Medicinal Products, Carabin, O., and Waeterloos Geneviève , Quality control and batch release of vaccines and blood products in Europe, 0/0/2015, Issue WIV-ISP, NA, (2015)
Semaine de la vaccination, Waeterloos, Geneviève , 0/4/2015, Brussels, Belgium, (2015)
Semaine mondiale de la vaccination 2015 : combler les lacunes en matière de vaccination, Waeterloos, Geneviève , 0/4/2015, Brussel, Belgium, (2015)

QR code

QR code for this page URL